BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11893788)

  • 1. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples.
    Oak JH; Nakagawa K; Miyazawa T
    J Lipid Res; 2002 Mar; 43(3):523-9. PubMed ID: 11893788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A UPLC-MRM-MS method for comprehensive profiling of Amadori compound-modified phosphatidylethanolamines in human plasma.
    He X; Li Z; Zhang Q
    Anal Bioanal Chem; 2021 Jan; 413(2):431-443. PubMed ID: 33111151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes.
    Nakagawa K; Oak JH; Higuchi O; Tsuzuki T; Oikawa S; Otani H; Mune M; Cai H; Miyazawa T
    J Lipid Res; 2005 Nov; 46(11):2514-24. PubMed ID: 16150834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Identification of Amadori Compound-Modified Phosphatidylethanolamines in Human Plasma.
    He X; Chen GY; Zhang Q
    Chem Res Toxicol; 2019 Jul; 32(7):1449-1457. PubMed ID: 31188577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry.
    Miyazawa T; Ibusuki D; Yamashita S; Nakagawa K
    Ann N Y Acad Sci; 2008 Apr; 1126():291-4. PubMed ID: 18448834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients.
    Suzuki K; Nakagawa K; Miyazawa T
    Clin Chem Lab Med; 2014 Jan; 52(1):47-52. PubMed ID: 23454716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem mass spectrometry analysis of Amadori-glycated phosphatidylethanolamine in human plasma.
    Miyazawa T; Oak JH; Nakagawa K
    Ann N Y Acad Sci; 2005 Jun; 1043():280-3. PubMed ID: 16037249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of deoxy-D-fructosyl phosphatidylethanolamine as a non-enzymic glycation product of phosphatidylethanolamine and its occurrence in human blood plasma and red blood cells.
    Lertsiri S; Shiraishi M; Miyazawa T
    Biosci Biotechnol Biochem; 1998 May; 62(5):893-901. PubMed ID: 9648220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetically prepared Aamadori-glycated phosphatidylethanolaminecan trigger lipid peroxidation via free radical reactions.
    Oak J; Nakagawa K; Miyazawa T
    FEBS Lett; 2000 Sep; 481(1):26-30. PubMed ID: 10984609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.
    Sookwong P; Nakagawa K; Fujita I; Shoji N; Miyazawa T
    Lipids; 2011 Oct; 46(10):943-52. PubMed ID: 21732214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes--influence of glycation products on lipid peroxidation.
    Breitling-Utzmann CM; Unger A; Friedl DA; Lederer MO
    Arch Biochem Biophys; 2001 Jul; 391(2):245-54. PubMed ID: 11437356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient method for preparation of high-purity, Amadori-glycated phosphatidylethanolamine and its prooxidant effect.
    Miyazawa T; Oak JH; Nakagawa K
    Ann N Y Acad Sci; 2005 Jun; 1043():276-9. PubMed ID: 16037248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of quantitation method for glycated aminophospholipids at the molecular species level in powdered milk and powdered buttermilk.
    Kodate A; Otoki Y; Shimizu N; Ito J; Kato S; Umetsu N; Miyazawa T; Nakagawa K
    Sci Rep; 2018 Jun; 8(1):8729. PubMed ID: 29880856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and quantification of aminophospholipid-linked Maillard compounds in model systems and egg yolk products.
    Utzmann CM; Lederer MO
    J Agric Food Chem; 2000 Apr; 48(4):1000-8. PubMed ID: 10775341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor.
    Higuchi O; Nakagawa K; Tsuzuki T; Suzuki T; Oikawa S; Miyazawa T
    J Lipid Res; 2006 May; 47(5):964-74. PubMed ID: 16470027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells.
    Oak JH; Nakagawa K; Oikawa S; Miyazawa T
    FEBS Lett; 2003 Dec; 555(2):419-23. PubMed ID: 14644453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatographic evidence for Amadori product formation in rat liver aminophospholipids.
    Pamplona R; Bellmunt MJ; Portero M; Riba D; Prat J
    Life Sci; 1995; 57(9):873-9. PubMed ID: 7630316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycation of plasma lipoprotein lipid membrane and screening for lipid glycation inhibitor.
    Nakagawa K; Ibusuki D; Yamashita S; Miyazawa T
    Ann N Y Acad Sci; 2008 Apr; 1126():288-90. PubMed ID: 18448833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic potency of Amadori-glycated phosphatidylethanolamine.
    Nakagawa K; Oak JH; Miyazawa T
    Ann N Y Acad Sci; 2005 Jun; 1043():413-6. PubMed ID: 16037263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study on the formation pathways of glycated phosphatidylethanolamine of food rich in phospholipid during the heat-processing.
    Lin Q; Han L; Liu G; Cheng W; Wang L
    RSC Adv; 2018 Mar; 8(21):11280-11288. PubMed ID: 35542782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.